Clearance of recalcitrant warts in a pediatric patient following administration of the nine-valent human papillomavirus vaccine

被引：9
|
作者：
Kost, Yana [1 ]
Zhu, Tian Hao [1 ]
Blasiak, Rachel C. [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
PEDIATRIC DERMATOLOGY | 2020年 / 37卷 / 04期
关键词：
infection-viral; warts; HPV;
D O I：
10.1111/pde.14150
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Verruca vulgaris is a common, benign infection of the skin and mucous membranes caused by human papillomavirus (HPV). Although many therapeutic options for warts exist, they have limited efficacy and there is no definitive cure for warts. We report the case of a 10-year-old girl with recalcitrant cutaneous warts persisting more than two years which resolved completely following vaccination with the nine-valent HPV vaccine.
引用
收藏
页码：748 / 749
页数：2
相关论文
共 50 条
  • [21] Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up
    Kjaer, Susanne K.
    Nygard, Mari
    Sundstrom, Karin
    Munk, Christian
    Berger, Sophie
    Dzabic, Mensur
    Fridrich, Katrin Elisabeth
    Waldstrom, Marianne
    Sorbye, Sveinung Wergeland
    Bautista, Oliver
    Group, Thomas
    Luxembourg, Alain
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (04) : 943 - 949
  • [22] Reinfection of Nine-Valent Human Papillomavirus Vaccine Types Among HIV-Negative Men Who Have Sex With Men: A Prospective Cohort Study
    Liu, Lirong
    Zhang, Guozhen
    Zhang, Zewen
    Wang, Lu
    Wang, Duolao
    Dai, Jianghong
    FRONTIERS IN PUBLIC HEALTH, 2022, 10 : 896479
  • [23] Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women
    Kjaer, Susanne K.
    Falkenthal, Thea E. Hetland
    Sundstroem, Karin
    Munk, Christian
    Sture, Tina
    Bautista, Oliver
    Rawat, Sonali
    Luxembourg, Alain
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [24] Comment on: "Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts"
    Taheri, Arash
    Mansoori, Parisa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (03) : E101 - E102
  • [25] Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial
    Thiem, Vu Dinh
    Quang, Nguyen Dang
    Tuan, Nguyen Hai
    Cheon, Kyeongmi
    Gallagher, Nancy
    Luxembourg, Alain
    Group, Thomas
    Badshah, Cyrus
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (07) : 1980 - 1985
  • [26] Panuveitis following administration of quadrivalent human papillomavirus vaccine
    Chen, Yu-Hung
    Chang, Ying-Hsiu
    Lee, Yuan-Chieh
    TZU CHI MEDICAL JOURNAL, 2014, 26 (01): : 44 - 46
  • [27] Reply to: "Comment on 'Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts'"
    Nofal, Ahmad
    Marei, Ayman
    Ibrahim, Al-shimaa M.
    Nofal, Eman
    Nabil, Manal
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (03) : E103 - E103
  • [28] Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial
    Huh, Warner K.
    Joura, Elmar A.
    Giuliano, Anna R.
    Iversen, Ole-Erik
    de Andrade, Rosires Pereira
    Ault, Kevin A.
    Bartholomew, Deborah
    Cestero, Ramon M.
    Fedrizzi, Edison N.
    Hirschberg, Angelica L.
    Mayrand, Marie-Helene
    Ruiz-Sternberg, Angela Maria
    Stapleton, Jack T.
    Wiley, Dorothy J.
    Ferenczy, Alex
    Kurman, Robert
    Ronnett, Brigitte M.
    Stoler, Mark H.
    Cuzick, Jack
    Garland, Suzanne M.
    Kjaer, Susanne K.
    Bautista, Oliver M.
    Haupt, Richard
    Moeller, Erin
    Ritter, Michael
    Roberts, Christine C.
    Shields, Christine
    Luxembourg, Alain
    LANCET, 2017, 390 (10108): : 2143 - 2159
  • [29] Immunogenicity and duration of antibodies after vaccination with a two-dose series of the nine-valent human papillomavirus vaccine among Alaska Native children: a prospective cohort study
    Jonathan Steinberg
    Gitika Panicker
    Elizabeth R. Unger
    Ian Blake
    Rayleen M. Lewis
    Jesse Geis
    Dana Bruden
    Marc Fischer
    Lauri E. Markowitz
    Michael G. Bruce
    BMC Infectious Diseases, 25 (1)
  • [30] Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts
    Marei, Ayman
    Nofal, Ahmad
    Alakad, Rania
    Abdel-Hady, Amina
    JOURNAL OF COSMETIC DERMATOLOGY, 2020, 19 (03) : 758 - 762
12345